$0.6022
At close: Aug 26, 3:20 PM EDT
$1.49
0.89147.43%
After Hours: Aug 22, 9:25 AM EDT
Comments
Loading...
Agile Therapeutics Inc COM PAR $0.0001 Stock Guidance | OTC:AGRX | Benzinga
Agile Therapeutics Inc COM PAR $0.0001 issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/09/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | — | $21.66M | Get Alert |
| 08/09/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | $30.00M | $21.66M | Get Alert |
| 05/11/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | $30.00M | $21.66M | Get Alert |
| 04/28/2023 | AGRX | Agile Therapeutics | Q1 | 2023 | — | — | — | $3.80M | $4.00M | $3.40M | Get Alert |
| 04/28/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | $30.00M | $21.66M | Get Alert |
| 03/22/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | $30.00M | $20.26M | Get Alert |
| 01/09/2023 | AGRX | Agile Therapeutics | FY | 2023 | — | — | — | $25.00M | $30.00M | $20.26M | Get Alert |
| 01/14/2021 | AGRX | Agile Therapeutics | Q4 | 2020 | — | — | — | $1.00M | $1.00M | $1.01M | Get Alert |
| 11/12/2020 | AGRX | Agile Therapeutics | Q4 | 2020 | — | — | — | $1.00M | $1.00M | $1.65M | Get Alert |
| 09/21/2020 | AGRX | Agile Therapeutics | Q4 | 2020 | — | — | — | $1.00M | $2.00M | — | Get Alert |
| 08/11/2020 | AGRX | Agile Therapeutics | Q4 | 2020 | — | — | — | $1.00M | $2.00M | — | Get Alert |
FAQ
What is the most recent guidance for Agile Therapeutics Inc COM PAR $0.0001 (AGRX)?
There have been no specific sales or earnings guidance reported for Agile Therapeutics Inc COM PAR $0.0001 in recent months.
Browse guidance and forecast on all stocks.
